Altered Nup153 Expression Impairs the Function of Cultured Hippocampal Neural Stem Cells Isolated from a Mouse Model of Alzheimer's Disease.
Alzheimer Disease
/ metabolism
Amyloid beta-Peptides
/ metabolism
Animals
Cell Differentiation
Cell Movement
Cell Proliferation
Cell Separation
Cells, Cultured
Disease Models, Animal
Mice, Transgenic
Neural Stem Cells
/ metabolism
Nitric Oxide
/ metabolism
Nitrosation
Nuclear Pore Complex Proteins
/ metabolism
SOXB1 Transcription Factors
/ metabolism
Signal Transduction
Adult hippocampal neurogenesis
Alzheimer’s disease
Neural stem cells
Nitric oxide
Nup153
Personalized medicine
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
02
09
2018
accepted:
20
12
2018
pubmed:
29
1
2019
medline:
18
12
2019
entrez:
29
1
2019
Statut:
ppublish
Résumé
Impairment of adult hippocampal neurogenesis is an early event in Alzheimer's disease (AD), playing a crucial role in cognitive dysfunction associated with this pathology. However, the mechanisms underlying defective neurogenesis in AD are still unclear. Recently, the nucleoporin Nup153 has been described as a new epigenetic determinant of adult neural stem cell (NSC) maintenance and fate. Here we investigated whether Nup153 dysfunction could affect the plasticity of NSCs in AD. Nup153 expression was strongly reduced in AD-NSCs, as well as its interaction with the transcription factor Sox2, a master regulator of NSC stemness and their neuronal differentiation. Similar Nup153 reduction was also observed in WT-NSCs treated with amyloid-β (Aβ) or stimulated with a nitric oxide donor. Accordingly, AD-NSCs treated with either a γ-secretase inhibitor or antioxidant compounds showed higher Nup153 levels suggesting that both nitrosative stress and Aβ accumulation affect Nup153 expression. Of note, restoration of Nup153 levels in AD-NSCs promoted their proliferation, as assessed by BrdU incorporation, neurosphere assay, and stemness gene expression analysis. Nup153 overexpression also recovered AD-NSC response to differentiation, increasing the expression of pro-neuronal genes, the percentage of cells positive for neuronal markers, and the acquisition of a more mature neuronal phenotype. Electrophysiological recordings revealed that neurons differentiated from Nup153-transfected AD-NSCs displayed higher Na
Identifiants
pubmed: 30689197
doi: 10.1007/s12035-018-1466-1
pii: 10.1007/s12035-018-1466-1
doi:
Substances chimiques
Amyloid beta-Peptides
0
Nuclear Pore Complex Proteins
0
Nup153 protein, mouse
0
SOXB1 Transcription Factors
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5934-5949Références
Neuromolecular Med. 2002;1(2):125-35
pubmed: 12025858
Cell Death Differ. 2004 Aug;11(8):862-74
pubmed: 15088071
Eur J Neurosci. 2004 Oct;20(8):2124-32
pubmed: 15450091
Nature. 2006 May 25;441(7092):513-7
pubmed: 16724068
J Clin Psychiatry. 2006 Nov;67(11):1784-800
pubmed: 17196061
Neuroscience. 2007 Oct 12;149(1):38-52
pubmed: 17870247
Biochim Biophys Acta. 2008 Mar;1783(3):405-18
pubmed: 18068677
Trends Cell Biol. 2008 Apr;18(4):174-83
pubmed: 18313922
Nature. 2008 Sep 18;455(7211):411-5
pubmed: 18754010
Curr Opin Neurobiol. 2008 Jun;18(3):245-50
pubmed: 18760361
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19183-7
pubmed: 19047631
J Clin Invest. 2009 May;119(5):1093-108
pubmed: 19363294
J Neurosci. 2009 May 20;29(20):6545-57
pubmed: 19458225
Cell Stem Cell. 2010 May 7;6(5):445-56
pubmed: 20452319
Eur J Neurosci. 2010 Sep;32(6):905-20
pubmed: 20726889
Mol Endocrinol. 2011 Dec;25(12):2003-16
pubmed: 22052999
Cell Res. 2012 Aug;22(8):1212-4
pubmed: 22410792
PLoS One. 2013 May 03;8(5):e62522
pubmed: 23658738
J Neurochem. 2013 Dec;127(5):691-700
pubmed: 23745722
J Alzheimers Dis. 2014;41(1):273-88
pubmed: 24614897
J Neurosci. 2014 Apr 2;34(14):5023-8
pubmed: 24695719
Neuropeptides. 2014 Jun;48(3):153-9
pubmed: 24703968
Development. 2014 May;141(10):1983-6
pubmed: 24803647
Biochim Biophys Acta. 2015 Feb;1849(2):210-6
pubmed: 24930777
Mol Neurodegener. 2014 Jun 25;9:25
pubmed: 24964731
Cell Rep. 2014 Dec 11;9(5):1908-1920
pubmed: 25482558
Genes Dev. 2015 Jun 15;29(12):1224-38
pubmed: 26080816
Mech Dev. 2015 Nov;138 Pt 1:56-62
pubmed: 26103548
Arch Toxicol. 2015 Oct;89(10):1669-80
pubmed: 26126631
Iran J Pharm Res. 2015 Summer;14(3):811-24
pubmed: 26330869
Curr Alzheimer Res. 2016;13(2):123-34
pubmed: 26391044
Prog Neurobiol. 2016 Mar-May;138-140:1-18
pubmed: 26855369
Oxid Med Cell Longev. 2016;2016:1805304
pubmed: 26881014
Neurobiol Aging. 2016 Oct;46:84-95
pubmed: 27460153
Curr Opin Cell Biol. 2017 Jun;46:26-32
pubmed: 28088069
Exp Neurol. 2017 May;291:36-43
pubmed: 28161255
Toxicology. 2017 Apr 15;381:19-30
pubmed: 28242320
Cardiovasc Res. 2016 Nov 1;112(2):555-567
pubmed: 28513807
Curr Top Dev Biol. 2017;125:257-273
pubmed: 28527574
Elife. 2017 Jul 11;6:
pubmed: 28696204
Cell Stem Cell. 2017 Nov 2;21(5):618-634.e7
pubmed: 28919367
Cell Tissue Res. 2018 Sep;373(3):693-709
pubmed: 29185071
Nat Commun. 2017 Dec 8;8(1):2009
pubmed: 29222408
Sci Rep. 2018 Jan 10;8(1):262
pubmed: 29321633
Bioelectrochemistry. 2018 Jun;121:142-150
pubmed: 29413864
Cereb Cortex. 2019 May 1;29(5):1851-1865
pubmed: 29790931
Oncotarget. 2018 Jun 15;9(46):27985-27997
pubmed: 29963256
Annu Rev Pharmacol Toxicol. 1995;35:213-33
pubmed: 7598492